Evidence map›Paper›PMID 32315537›Full record

Trial reportJournal of child and adolescent psychopharmacology2020

Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment Resistance.

Jeffrey R Strawn, Scott T Aaronson, Ahmed Z Elmaadawi, G Randolph Schrodt, Richard C Holbert, Sarah Verdoliva, Karen Heart, Mark A Demitrack, Paul E Croarkin

Open access · greenAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of child and adolescent psychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Jeffrey R StrawnDepartment of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Scott T AaronsonSheppard Pratt Health System, Baltimore, Maryland, USA.
Ahmed Z ElmaadawiIndiana University School of Medicine, Beacon Health System, South Bend, Indiana, USA.
G Randolph SchrodtIntegrative Psychiatry, Louisville, Kentucky, USA.
Richard C HolbertShands Psychiatric Hospital, University of Florida Department of Psychiatry, Gainsville, Florida, USA.
Sarah VerdolivaNAMSA, Minneapolis, Minnesota, USA.
Karen HeartNeuronetics, Inc., Malvern, Pennsylvania, USA.
Mark A DemitrackTrevena, Inc., Chesterbrook, Pennsylvania, USA.
Paul E CroarkinDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
Indiana University School of MedicineIntegrative Medicine Institute · USMayo Clinic · USNational Alliance on Mental Illness · USNeuronetics (United States) · USSheppard Pratt Health System · USUniversity of Cincinnati Medical Center · US

Funding

Estracellular Vesicles as Non-Invasive Predictors of Antidepressant Outcomes in Pediatric AnxietyR01HD098757 · NICHD · UNIVERSITY OF CINCINNATI · PI STRAWN, JEFFREY ROBERT · 2019 to 2024
$2.4M
NICHD NIH HHS R01 HD098757
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAntidepressive AgentsChildDepressive Disorder, Treatment-ResistantFemaleHumansMajor Depressive DisorderMaleProspective StudiesPsychiatric Status Rating ScalesRecurrenceSelective Serotonin Reuptake InhibitorsSeverity of Illness IndexTime FactorsYoung AdultAntidepressive AgentsSelective Serotonin Reuptake Inhibitorsantidepressantdepressionmajor depressive disorder

Identifiers

PMID32315537
PMCPMC7640745
OpenAlexW3016501545

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.